Ovarian Cancer in BRCA Mutation Carriers: Improved Outcome After Intraperitoneal (IP) CisplatinMaryann Kwa, Franco M. Muggia, Andrea Downey et al.|Annals of Surgical Oncology|2013Cited by 30